Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab
- Resource Type
- Abstract
- Source
- In
Journal of the Neurological Sciences October 2021 429 Supplement - Subject
- Language
- ISSN
- 0022-510X